Are you recommending tocilizumab for any COVID-19 patients?
Current guidelines do not support its use, but the EMPACTA trial suggests it may be effective in a subpopulation of patients.
Community PollStarted
Are you recommending IL-6 receptor inhibitor therapy for any COVID-19 patients?
11 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet Member
Rheumatology · Northwestern Medical Group
Answered on
The utility of IL-6 receptor inhibitors in COVID-19 is controversial, and I do not recommend its routine use in COVID-19 patients at this time. Although early observational studies of IL-6 receptor inhibitors in severe COVID-19 suggested potential benefits, an early RCT of tocilizumab vs. placebo (B...
Join for free or sign in to see the full answer